Giulia Ruozi

Trieste, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

EMID2 is a novel biotherapeutic for aggressive cancers identified by in vivo screening.

EMID2 is a novel biotherapeutic for aggressive cancers identified by in vivo screening.

Journal: Journal of experimental & clinical cancer research : CR
Published: September 30, 2023

Cardioprotective factors against myocardial infarction selected in vivo from an AAV secretome library.

Cardioprotective factors against myocardial infarction selected in vivo from an AAV secretome library.

Journal: Science translational medicine
Published: August 31, 2022

n-3 PUFA dietary lipid replacement normalizes muscle mitochondrial function and oxidative stress through enhanced tissue mitophagy and protects from muscle wasting in experimental kidney disease.

n-3 PUFA dietary lipid replacement normalizes muscle mitochondrial function and oxidative stress through enhanced tissue mitophagy and protects from muscle wasting in experimental kidney disease.

Journal: Metabolism: clinical and experimental
Published: February 17, 2022

AAV9-mediated functional screening for cardioprotective cytokines in Coxsackievirus-B3-induced myocarditis.

AAV9-mediated functional screening for cardioprotective cytokines in Coxsackievirus-B3-induced myocarditis.

Journal: Scientific reports
Published: October 01, 2021

Acylated ghrelin treatment normalizes skeletal muscle mitochondrial oxidative capacity and AKT phosphorylation in rat chronic heart failure.

Acylated ghrelin treatment normalizes skeletal muscle mitochondrial oxidative capacity and AKT phosphorylation in rat chronic heart failure.

Journal: Journal of cachexia, sarcopenia and muscle
Published: September 28, 2017

In Vivo Functional Selection Identifies Cardiotrophin-1 as a Cardiac Engraftment Factor for Mesenchymal Stromal Cells.

In Vivo Functional Selection Identifies Cardiotrophin-1 as a Cardiac Engraftment Factor for Mesenchymal Stromal Cells.

Journal: Circulation
Published: April 17, 2017

Unacylated Ghrelin Enhances Satellite Cell Function and Relieves the Dystrophic Phenotype in Duchenne Muscular Dystrophy mdx Model.

Unacylated Ghrelin Enhances Satellite Cell Function and Relieves the Dystrophic Phenotype in Duchenne Muscular Dystrophy mdx Model.

Journal: Stem cells (Dayton, Ohio)
Published: August 10, 2016

In vivo selection of novel biotherapeutics.

In vivo selection of novel biotherapeutics.

Journal: Oncotarget
Published: August 07, 2015

Unacylated Ghrelin Reduces Skeletal Muscle Reactive Oxygen Species Generation and Inflammation and Prevents High-Fat Diet-Induced Hyperglycemia and Whole-Body Insulin Resistance in Rodents.

Unacylated Ghrelin Reduces Skeletal Muscle Reactive Oxygen Species Generation and Inflammation and Prevents High-Fat Diet-Induced Hyperglycemia and Whole-Body Insulin Resistance in Rodents.

Journal: Diabetes
Published: July 22, 2015

AAV-mediated in vivo functional selection of tissue-protective factors against ischaemia.

AAV-mediated in vivo functional selection of tissue-protective factors against ischaemia.

Journal: Nature communications
Published: September 16, 2014

In vivo therapeutic potential of mesenchymal stromal cells depends on the source and the isolation procedure.

In vivo therapeutic potential of mesenchymal stromal cells depends on the source and the isolation procedure.

Journal: Stem cell reports
Published: August 06, 2014

Neuropilin-1 identifies a subset of bone marrow Gr1- monocytes that can induce tumor vessel normalization and inhibit tumor growth.

Neuropilin-1 identifies a subset of bone marrow Gr1- monocytes that can induce tumor vessel normalization and inhibit tumor growth.

Journal: Cancer research
Published: December 11, 2012
Showing 1-12 of 12

Last Updated: 09/26/2026